603127 昭衍新药
2025/06 - 中期
人民币(K¥)
与去年末期
比较
2024/12
人民幣(K¥)
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
2021/12
人民幣(K¥)

非流动资产
长期股权投资0--019,52922,59825,289
投资性房地产0--0000
固定资产790,95913.52%696,786583,319590,214493,153
在建工程286,538-22.33%368,927342,008277,735127,361
无形资产290,546-2.67%298,514292,380299,536137,193
商誉137,465-0.41%138,037136,007133,739122,431
其他非流动资产2,688,002-6.10%2,862,6911,531,9503,111,9881,817,166
4,193,509-3.93%4,364,9552,905,1924,435,8102,722,593

流动资产
货币资金662,232-31.39%965,2032,862,9122,916,8484,154,099
应收账款159,155-12.15%181,168206,014199,437107,606
存货1,560,9695.57%1,478,5471,863,0822,194,606700,587
其他流动资产2,897,59720.42%2,406,2802,189,959617,516852,192
5,279,9534.94%5,031,1987,121,9675,928,4065,814,484

流动负债
短期借款0--0000
应付票据0--0000
应付帐款52,8215.18%50,22243,323127,30953,644
其他流动负债1,114,3275.09%1,060,3461,424,0421,716,9531,160,598
1,167,1485.09%1,110,5691,467,3651,844,2621,214,242
流动资产净值4,112,8044.90%3,920,6295,654,6024,084,1444,600,242
资产总额减流动负债8,306,3140.25%8,285,5848,559,7958,519,9537,322,835

非流动负债
长期借款0--003,2814,939
应付债券0--0000
其他非流动负债201,247-2.49%206,396278,754325,807173,460
201,247-2.49%206,396278,754329,087178,399

总权益
    实收股本749,4770.00%749,477749,889535,679381,246
    储备项目7,355,2190.35%7,329,3417,529,4277,648,0236,754,968
股东权益8,104,6970.32%8,078,8198,279,3168,183,7017,136,214
非控股权益3700.00%3701,7257,1658,222